Tetralogic Pharmaceuticals Corp Stock Probability of Future Pink Sheet Price Finishing Over 1.0E-4
| TLOG Stock | USD 0.0001 0.00 0.00% |
TetraLogic |
TetraLogic Pharmaceuticals Target Price Odds to finish over 1.0E-4
The tendency of TetraLogic Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 68.72 |
Based on a normal probability distribution, the odds of TetraLogic Pharmaceuticals to move above the current price in 90 days from now is about 68.72 (This TetraLogic Pharmaceuticals Corp probability density function shows the probability of TetraLogic Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 1.05 . This usually implies TetraLogic Pharmaceuticals Corp market returns are reactive to returns on the market. As the market goes up or down, TetraLogic Pharmaceuticals is expected to follow. Additionally TetraLogic Pharmaceuticals Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. TetraLogic Pharmaceuticals Price Density |
| Price |
Predictive Modules for TetraLogic Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as TetraLogic Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.TetraLogic Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. TetraLogic Pharmaceuticals is not an exception. The market had few large corrections towards the TetraLogic Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold TetraLogic Pharmaceuticals Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of TetraLogic Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.87 | |
β | Beta against Dow Jones | 1.05 | |
σ | Overall volatility | 0.000041 | |
Ir | Information ratio | -0.14 |
TetraLogic Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of TetraLogic Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for TetraLogic Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| TetraLogic Pharmaceuticals generated a negative expected return over the last 90 days | |
| TetraLogic Pharmaceuticals has high historical volatility and very poor performance | |
| TetraLogic Pharmaceuticals has some characteristics of a very speculative penny stock | |
| TetraLogic Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| TetraLogic Pharmaceuticals Corp currently holds 28.33 M in liabilities with Debt to Equity (D/E) ratio of 4.17, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TetraLogic Pharmaceuticals has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist TetraLogic Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, TetraLogic Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TetraLogic Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TetraLogic to invest in growth at high rates of return. When we think about TetraLogic Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (49.72 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TetraLogic Pharmaceuticals Corp currently holds about 5.89 M in cash with (34.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
TetraLogic Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of TetraLogic Pink Sheet often depends not only on the future outlook of the current and potential TetraLogic Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. TetraLogic Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.7 M | |
| Cash And Short Term Investments | 20.4 M |
TetraLogic Pharmaceuticals Technical Analysis
TetraLogic Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. TetraLogic Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of TetraLogic Pharmaceuticals Corp. In general, you should focus on analyzing TetraLogic Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
TetraLogic Pharmaceuticals Predictive Forecast Models
TetraLogic Pharmaceuticals' time-series forecasting models is one of many TetraLogic Pharmaceuticals' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary TetraLogic Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about TetraLogic Pharmaceuticals
Checking the ongoing alerts about TetraLogic Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for TetraLogic Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| TetraLogic Pharmaceuticals generated a negative expected return over the last 90 days | |
| TetraLogic Pharmaceuticals has high historical volatility and very poor performance | |
| TetraLogic Pharmaceuticals has some characteristics of a very speculative penny stock | |
| TetraLogic Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| TetraLogic Pharmaceuticals Corp currently holds 28.33 M in liabilities with Debt to Equity (D/E) ratio of 4.17, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TetraLogic Pharmaceuticals has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist TetraLogic Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, TetraLogic Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TetraLogic Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TetraLogic to invest in growth at high rates of return. When we think about TetraLogic Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (49.72 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| TetraLogic Pharmaceuticals Corp currently holds about 5.89 M in cash with (34.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Other Information on Investing in TetraLogic Pink Sheet
TetraLogic Pharmaceuticals financial ratios help investors to determine whether TetraLogic Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in TetraLogic with respect to the benefits of owning TetraLogic Pharmaceuticals security.